Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines

Nutrition and Cancer

Volumn 64, Issue 7, 2012, Pages 1103-1111

  Orlando, A ^a   Refolo, M G ^a   Messa, C ^a   Amati, L ^a   Lavermicocca, P ^b   Guerra, V ^a   Russo, F ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b INSTITUTE OF SCIENCES OF FOOD PRODUCTION   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; LACTOBACILLUS PARACASEI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; NUCLEOTIDE SEQUENCE; STOMACH CANCER;

APOPTOSIS; BACTERIAL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; COLON; COLONIC NEOPLASMS; FECES; HUMANS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PROBIOTICS; STOMACH; STOMACH NEOPLASMS;

EID: 84867817606     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.717676     Document Type: Article

References (47)

1. Brenner, H, Rothenbacher, D, and, Arndt, V. 2009. Epidemiology of stomach cancer. Methods Mol Biol, 472: 467-477.
2. Lepage, C, Hamza, S, and, Faivre, J. 2010. Epidemiology and screening of colon cancer. Rev Prat, 60: 1062-1067.
3. Bazuro, G E, Torino, F, Gasparini, G, and, Capurso, L. 2008. Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all?. Minerva Gastroenterol Dietol, 54: 429-444.
4. Aureli, P, Capurso, L, Castellazzi, A M, Clerici, M, Giovannini, M. 2011. Probiotics and health: An evidence-based review. Pharmacol Res, 63: 366-376.
5. Rafter, J. 2003. Probiotics and colon cancer. Best Pract Res Clin Gastroenterol, 17: 849-859.
6. Saikali, J, Picard, C, Freitas, M, and, Holt, P. 2004. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer, 49: 14-24.
7. Linsalata, M, Russo, F, Berloco, P, Valentini, A M, Caruso, M L. 2005. Effects of probiotic bacteria (VSL#3) on the polyamine biosynthesis and cell proliferation of normal colonic mucosa of rats. In Vivo, 19: 989-995.
8. de Moreno de Leblanc, A, and, Perdigón, G. 2010. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc, 16: 1-8.
9. Marteau, P, Minekus, M, Havenaar, R, and, Huis in't Veld, J H. 1997. Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci, 80: 1031-1037.
10. Fuller, R. 1989. Probiotics in man and animal. J Appl Bacteriol, 66: 365-378.
11. Linsalata, M, Russo, F, Berloco, P, Caruso, M L, Di Matteo, G. 2004. The influence of Lactobacillus brevis on ornithine decarboxylase activity and polyamine profiles in Helicobacter pylori -infected gastric mucosa. Helicobacter, 9: 165-172.
12. Francavilla, R, Lionetti, E, Castellaneta, S P, Magist, A M, Maurogiovanni, G. 2008. Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study. Helicobacter, 13: 127-134.
13. Lin, W H, Wu, C R, Fang, T J, Guo, J T, Huang, S Y. 2011. Anti- Helicobacter pylori activity of fermented milk with lactic acid bacteria. J Sci Food Agric, 91: 1424-1431.
14. Russo, F, Orlando, A, Linsalata, M, Cavallini, A, and, Messa, C. 2007. Effects of Lactobacillus rhamnosus GG on the cell growth and polyamine metabolism in HGC-27 human gastric cancer cells. Nutr Cancer, 59: 106-114.
15. Orlando, A, Messa, C, Linsalata, M, Cavallini, A, and, Russo, F. 2009. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol Immunotoxicol, 31: 108-116.
16. Linsalata, M, Cavallini, A, Messa, C, Orlando, A, Refolo, M G. 2010. Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cancer. Curr Pharm Des, 16: 847-853.
17. Lombardo, L. 2008. New insights into Lactobacillus and functional intestinal disorders. Minerva Gastroenterol Dietol, 54: 287-293.
18. Valerio, F, de Candia, S, Lonigro, S L, Russo, F, Riezzo, G. 2011. Role of the probiotic strain Lactobacillus paracasei LMGP22043 carried by artichokes in influencing faecal bacteria and biochemical parameters in human subjects. J Appl Microbiol, 111: 155-164.
19. DArienzo, R, Maurano, F, Lavermicocca, P, Ricca, E, and, Rossi, M. 2009. Modulation of the immune response by probiotic strains in a mouse model of gluten sensitivity. Cytokine, 48: 254-259.
20. Lavermicocca, P, Valerio, F, Lonigro, S L, Di Leo, A, and, Visconti, A. 2008. Antagonistic activity of potential probiotic Lactobacilli against the ureolytic pathogen Yersinia enterocolitica. Curr Microbiol, 56: 175-181.
21. Lavermicocca, P, Lonigro, S L, Visconti, A, De Angelis, M, Valerio, F. 2009. Patent: table olives containing probiotic microorganisms. Priority date: 5.12.2003 no. MI2003A002391. European Patent EP1843664 (granted 8.7.09)
22. Collins, M D, and, Gibson, G R. 1999. Probiotics, prebiotics and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr, 69: 1052S-1057S.
23. Rafter, J. 2004. The effect s of probiotics on colon cancer development. Nutr Res Reviews, 17: 277-284.
24. Reid, G, Jass, J, Sebulsky, M T, and, McCormick, J K. 2003. Potential uses of probiotics in clinical practice. Clin Microbiol Rev, 16: 658-672.
25. De Preter, V, Hamer, H M, Windey, K, and, Verbeke, K. 2011. The impact of pre- and/or probiotics on human colonic metabolism: does it affect human health?. Mol Nutr Food Res, 55: 46-57.
26. Kumar, M, Kumar, A, Nagpal, R, Mohania, D, Behare, P. 2010. Cancer-preventing attributes of probiotics: an update. Int J Food Sci Nutr, 61: 473-496.
27. Guengerich, F P. 2003. Cytochromes P450, drugs, and diseases. Mol Interv, 3: 194-204.
28. Moorehead, R J, Hoper, M, and, McKelvey, S TD. 1987. Assessment of ornithine decarboxylase in rectal mucosa as a marker for colorectal adenomas and carcinomas. Br J Surg, 74: 364-365.
29. Liong, M T. 2008. Roles of probiotics and prebiotics in colon cancer prevention: Postulated mechanisms and in-vivo evidence. Int J Mol Sci, 9: 854-863.
30. Park, S K, Park, D I, Choi, J S, Kang, M S, Park, J H. 2007. The effect of probiotics on Helicobacter pylori eradication. Hepatogastroenterology, 54: 2032-2036.
31. Saxelin, M. 1997. Lactobacillus GG-a human probiotic strain with thorough clinical documentation. Food Rev Int, 13: 293-313.
32. Peluso, I, Fina, D, Caruso, R, Stolfi, C, Caprioli, F. 2007. Lactobacillus paracasei subsp. paracasei B21060 suppresses human T-cell proliferation. Infect Immun, 75: 1730-1737.
33. Corcoran, B M, Stanton, C, Fitzgerald, G F, and, Ross, R P. 2005. Survival of probiotic lactobacilli in acidic environments is enhanced in the presence of metabolizable sugars. Appl Environ Microbiol, 71: 3060-3067.
34. Tuomola, E M, and, Salminen, S J. 1998. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures. Int J Food Microbiol, 41: 45-51.
35. Klingberg, T D, Axelsson, L, Naterstad, K, Elsser, D, and, Budde, B B. 2005. Identification of potential probiotic starter cultures for Scandinavian-type fermented sausages. Int J Food Microbiol, 105: 419-431.
36. Ouwehand, A C, Salminen, S, Tlkk, S, Roberts, P, Ovaska, J. 2002. Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. Clin Diagn Lab Immunol, 9: 184-186.
37. Greene, J D, and, Klaenhammer, T R. 1994. Factors involved in adherence of lactobacilli to human Caco-2 cells. Appl Environ Microbiol, 60: 4487-4494.
38. Kabir, A M, Aiba, Y, Takagi, A, Kamiya, S, Miwa, T. 1997. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut, 41: 49-55.
39. Nam, H, Ha, M, Bae, O, and, Lee, Y. 2002. Effect of Weissella confuse strain PL9001 on the adherence and growth of Helicobacter pylori. Appl Environ Microbiol, 68: 4642-4645.
40. Carlson, D A, and, Ribeiro, J M. 1993. Apoptosis and disease. Lancet, 341: 1251-1254.
41. Hu, W, and, Kavanagh, J J. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol, 4: 721-729.
42. Kataria, J, Li, N, Wynn, J L, and, Neu, J. 2009. Probiotic microbes: do they need to be alive to be beneficial?. Nutr Rev, 67: 546-550.
43. Choi, S S, Kim, Y, Han, K S, You, S, Oh, S. 2006. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol, 42: 452-458.
44. Ma, E L, Choi, Y J, Choi, J, Pothoulakis, C, Rhee, S H. 2010. The anticancer effect of probiotic Bacillus polyfermenticus on human colon cancer cells is mediated through ErbB2 and ErbB3 inhibition. Int J Cancer, 127: 780-790.
45. Sashihara, T, Sueki, N, and, Ikegami, S. 2006. An analysis of the effectiveness of heat-killed lactic acid bacteria in alleviating allergic diseases. J Dairy Sci, 89: 2846-2855.
46. Adams, C A. 2010. The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev, 23: 37-46.
47. Dotan, I, and, Rachmilewitz, D. 2005. Probiotics in inflammatory bowel disease: possible mechanisms of action. Curr Opin Gastroenterol, 21: 426-430.